NDAINTRAVENOUSINJECTABLEPriority Review
Approved
Apr 2006
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
(PDA) in neonates is not known. In adults, ibuprofen is an inhibitor of prostaglandin synthesis.
Loss of Exclusivity
LOE Date
Mar 2, 2032
73 months away
Patent Expiry
Mar 2, 2032
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8415337 | Mar 2, 2032 | SubstanceProduct | — |